Developing guidelines for reporting healthcare research: Scientific rationale and procedures;Elaboración de directrices para la publicación de investigación biomédica: Proceso y fundamento científico

Medicina Clinica

Volumn 125, Issue SUPPL. 1, 2005, Pages 8-13

  Altman, Douglas G ^a   Moher, David ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

CONSORT; Guidelines; QUOROM; Reporting research; STARD

Indexed keywords

ARTICLE; EVIDENCE BASED MEDICINE; HEALTH CARE; MEDICAL LITERATURE; MEDICAL RESEARCH; PRACTICE GUIDELINE; PROPHYLAXIS;

AUTHORSHIP; CHECKLIST; GUIDELINES AS TOPIC; HEALTH SERVICES RESEARCH; PERIODICALS AS TOPIC; POLICY MAKING; PUBLISHING; RESEARCH REPORT;

EID: 33947270730     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/s0025-7753(05)72203-x     Document Type: Article

References (61)

1. CenterWatch. Disponible en: http://www.centerwatch.com/
2. Wilczynski NL, Morgan D, Haynes RB. An overview of the design and methods for retrieving high-quality studies for clinical care. BMC Med Inform Decis Mak. 2005;5:20.
3. Weiner JM, Shirley S, Gilman NJ, Stowe SM, Wolf RM. Access to data and the information explosion: oral contraceptives and risk of cancer. Contraception. 1981;24:301-13.
4. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134:663-94.
5. Bentzen SM. Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy. Radiother Oncol. 1998;46:5-18.
6. Harrison JE. Clinical trials in orthodontics II: assessment of the quality of reporting of clinical trials published in three orthodontic journals between 1989 and 1998. J Orthod. 2003;30:309-15.
7. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem. 2003;49:7-18.
8. Des Jarlais DC, Lyles C, Crepaz N, and the TREND Group. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health. 2004;94:361-6.
9. Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ. 1998;317:1181-4.
10. Reid MC, Lachs MS, Feinstein AR. Use of methodological standards in diagnostic test research. Getting better but still not good. JAMA. 1995;274:645-51.
11. Von Elm E, Egger M. The scandal of poor epidemiological research. BMJ. 2004;329:868-9.
12. Pocock SJ, Collier TJ, Dandreo KJ, De Stavola BL, Goldman MB, Kalish LA, et al. Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ. 2004;329:883.
13. Godlee F, Jefferson T. Peer review in health sciences. London: BMJ Books; 2003.
14. Gardner MJ, Altman DG. Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J. 1986;292:746-50.
15. Braitman LE. Confidence intervals extract clinically useful information from data. Ann Intern Med. 1988;108:296-8.
16. Langman MJS. Towards estimation and confidence intervals. Br Med J. 1986;292:716.
17. Bulpitt CJ. Confidence intervals. Lancet. 1987;1:494-7.
18. Berry G. Statistical significance and confidence intervals. Med J Aust. 1986;144:618-9.
19. Fleiss JL. Confidence intervals vs significance tests: quantitative interpretation. Am J Public Health. 1986;76:587-8.
20. Report with confidence. Lancet. 1987;1:488.
21. Gardner MJ, Altman DG. Estimating with confidence. BMJ. 1988;296:1210-1.
22. Rothman KJ. A show of confidence. N Engl J Med. 1978;299:1362-3.
23. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. BMJ. 1988;296:401-5.
24. Seldrup J. Whatever happened to the t-test. Drug Inf J. 1997;31:745-50.
25. Savitz DA, Tolo KA, Poole C. Statistical significance testing in the American Journal of Epidemiology, 1970-1990. Am J Epidemiol. 1994;139:1047-52.
26. Walter SD. Methods of reporting statistical results from medical research studies. Am J Epidemiol. 1995;141:896-906.
27. Altman DG. Confidence intervals in practice. En: Altman DG, Machin D, Bryant T, Gardner MJ, editors. Statistics with confidence. London: BMJ Books; 2000. p. 6-14.
28. Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. En: Altman DG, Machin D, Bryant TN, Gardner MJ, editors. Statistics with confidence. London: BJM Books; 2000. p. 171-90.
29. Daniels M. Scientific appraisement of new drugs in tuberculosis. Am Rev Tuberc. 1950;61:751-6.
30. Squires BP, Elmslie TJ. Reports of randomized controlled trials: what editors want from authors and peer reviewers. CMAJ. 1990;143:381-2.
31. Squires BP, Elmslie TJ. Cohort studies: what editors want from authors and peer reviewers. CMAJ. 1990;143:179-80.
32. Squires BP, Elmslie TJ. Reports of case-control studies: what editors want from authors and peer reviewers. CMAJ. 1990;143:17-8.
33. Squires BP. Statistics in biomedical manuscripts: what editors want from authors and peer reviewers. CMAJ. 1990;142:213-4.
34. The Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. JAMA. 1994;272:1926-31.
35. The Asilomar Working Group On Recommendations For Reporting Of Clinical Trials In The Biomedical Literature. Checklist of information for inclusion in reports of clinical trials. Ann Intern Med. 1996;124:741-3.
36. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276:637-9.
37. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA. 2001;285:1987-91.
38. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134:663-94.
39. Ioannidis JPA, Evans SJW, Gøtzsche PC, O'Neill RT, Altman DG, Schulz KF, et al, for the CONSORT Group. Improving the reporting of harms in randomized trials: Expansion of the CONSORT statement. Ann Intern Med. 2004;141:781-8.
40. Campbell MK, Elbourne DR, Altman DG. CONSORT statement: extension to cluster randomised trials. BMJ. 2004;328:702-8.
41. MacPherson H, White A, Cummings M, Jobst K, Rose K, Niemtzow R. Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations. Complement Ther Med. 2001;9:246-9.
42. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Chem. 2003;49:1-6.
43. Des J, Lyles C, Crepaz N. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health. 2004;94:361-6.
44. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses [see comments]. Lancet. 1999;354:1896-900.
45. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-12.
46. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer. 2005;93:387-91.
47. Woolf SH. Practice guidelines, a new reality in medicine. II. Methods of developing guidelines. Arch Intern Med. 1992;152:946-52.
48. Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature. Call for comments on a proposal to improve reporting of clinical trials in the biomedical literature. Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature. Ann Intern Med. 1994;121:894-5.
49. Egger M, Juni P, Bartlett C. Value of flow diagrams in reports of randomized controlled trials. JAMA. 2001;285:1996-9.
50. Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA. 2001;285:1992-5.
51. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-12.
52. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998;352:609-13.
53. Altman DG. Better reporting of randomised controlled trials: the CONSORT statement. BMJ. 1996;313:570-1.
54. Grimes DA, Hubacher D, Nanda K, Schulz KF, Moher D, Altman DG. The Good Clinical Practice guideline: a bronze standard for clinical research. Lancet. 2005;366:172-4.
55. Meinert CL. Beyond CONSORT: Need for improved reporting standards for clinical trials. JAMA. 1998;279:1487-9.
56. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ. 1999;319:670-4.
57. Ruiz-Canela M, Martínez-González MA, de Irala-Estévez J. Intention to treat analysis is related to methodological quality. BMJ. 2000;320:1007-8.
58. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004;8:III-72.
59. Rennie D. Fourth International Congress on Peer Review in Biomedical Publication. JAMA. 2002;287:2759-60.
60. Plint AC, Moher D, Schulz K, Altman DG, Morrison A. Does the CONSORT checklist improve the quality of reports of randomized controlled trials? A systematic review. Fifth International Congress on Peer Review and Biomedical Publication. Chicago: 2005.
61. Smidt N, Rutjes AWS, Van der Windt DAWM, Ostelo RWJG, Reitsma JB, Bossuyt PM, et al. Does the STARD Statement Improve the Quality of Reporting of Diagnostic Accuracy Studies? Fifth International Congress on Peer Review and Biomedical Publication. Chicago: 2005.